TY - JOUR
T1 - The Yin and Yang of bacterial resilience in the human gut microbiota
AU - Gibson, Molly K.
AU - Pesesky, Mitchell W.
AU - Dantas, Gautam
N1 - Funding Information:
This work was supported in part by the National Institutes of Health Director's New Innovator Award † † , the National Institute of Diabetes and Digestive and Kidney Diseases † 2 , and the National Institute of General Medical Sciences † 3 of the National Institutes of Health under award numbers DP2DK098089 and R01GM099538 to G.D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported in part by the Kenneth Rainin Foundation Breakthrough Award ( 13H5 ) to G.D. M.K.G. is a National Science Foundation graduate research fellow (award number DGE-11143954) and a Mr. and Mrs. Spencer T. Olin Fellow. M.W.P. is funded by the National Institute of General Medical Sciences Cell and Molecular Biology Training Grant (GM:007067).
Publisher Copyright:
© 2014 Elsevier Ltd. All rights reserved.
PY - 2014/11/25
Y1 - 2014/11/25
N2 - The human gut is home to trillions of microbes that form a symbiotic relationship with the human host. During health, the intestinal microbiota provides many benefits to the host and is generally resistant to colonization by new species; however, disruption of this complex community can lead to pathogen invasion, inflammation, and disease. Restoration and maintenance of a healthy gut microbiota composition requires effective therapies to reduce and prevent colonization of harmful bacteria (pathogens) while simultaneously promoting growth of beneficial bacteria (probiotics). Here we review the mechanisms by which the host modulates the gut community composition during health and disease, and we discuss prospects for antibiotic and probiotic therapy for restoration of a healthy intestinal community following disruption.
AB - The human gut is home to trillions of microbes that form a symbiotic relationship with the human host. During health, the intestinal microbiota provides many benefits to the host and is generally resistant to colonization by new species; however, disruption of this complex community can lead to pathogen invasion, inflammation, and disease. Restoration and maintenance of a healthy gut microbiota composition requires effective therapies to reduce and prevent colonization of harmful bacteria (pathogens) while simultaneously promoting growth of beneficial bacteria (probiotics). Here we review the mechanisms by which the host modulates the gut community composition during health and disease, and we discuss prospects for antibiotic and probiotic therapy for restoration of a healthy intestinal community following disruption.
KW - antibiotic resistance
KW - bacterial resilience
KW - genetic engineering
KW - human gut microbiota
KW - probiotics
UR - http://www.scopus.com/inward/record.url?scp=84910116769&partnerID=8YFLogxK
U2 - 10.1016/j.jmb.2014.05.029
DO - 10.1016/j.jmb.2014.05.029
M3 - Review article
C2 - 24911583
AN - SCOPUS:84910116769
SN - 0022-2836
VL - 426
SP - 3866
EP - 3876
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 23
ER -